tiprankstipranks
Trending News
More News >
Good Fellow Healthcare Holdings Limited (HK:8143)
:8143
Hong Kong Market

Good Fellow Healthcare Holdings Limited (8143) AI Stock Analysis

Compare
0 Followers

Top Page

HK

Good Fellow Healthcare Holdings Limited

(8143)

Rating:51Neutral
Price Target:
The overall score reflects significant financial challenges, including declining revenue and profitability issues. Despite upward momentum in technical analysis, the stock appears overbought, increasing the risk of a correction. The valuation is weak due to a negative P/E ratio and lack of dividends.

Good Fellow Healthcare Holdings Limited (8143) vs. iShares MSCI Hong Kong ETF (EWH)

Good Fellow Healthcare Holdings Limited Business Overview & Revenue Model

Company DescriptionGood Fellow Healthcare Holdings Limited, an investment holding company, provides general hospital services in the People's Republic of China and internationally. Its general hospital services include medical and surgical wards, and medical checkup and examination. As of March 31, 2022, the company operated two general hospitals in Putain and Beijing. It also provides medical investment and hospital management services; and hospital consulting management. The company was formerly known as Hua Xia Healthcare Holdings Limited and changed its name to Good Fellow Healthcare Holdings Limited in February 2019. The company was incorporated in 2001 and is headquartered in Central, Hong Kong. Good Fellow Healthcare Holdings Limited is a subsidiary of Solar Star Global Limited.
How the Company Makes MoneyGood Fellow Healthcare Holdings Limited generates revenue through multiple streams within the healthcare sector. This includes income from medical services provided at its facilities, sales of healthcare-related products, and possibly collaborations with other healthcare entities. The company may also benefit from government healthcare programs or private partnerships that contribute to its financial stability. The diversification within the healthcare services and product offerings helps in maintaining a steady flow of income.

Good Fellow Healthcare Holdings Limited Financial Statement Overview

Summary
Good Fellow Healthcare Holdings Limited is facing significant financial challenges, as evidenced by declining revenues, persistent net losses, and a weakening balance sheet. The company is under pressure with high leverage and cash flow constraints, suggesting a need for strategic restructuring to improve financial health and performance.
Income Statement
52
Neutral
The company has experienced a significant decline in revenue over the past few years, with a revenue decrease from $144.59 million in 2020 to $38.96 million in 2024. Gross profit margin has also deteriorated, alongside negative EBIT and net profit margins, indicating operational challenges. The continued negative net income suggests persistent profitability issues.
Balance Sheet
45
Neutral
The balance sheet shows a high leverage with a debt-to-equity ratio increasing due to rising total liabilities and decreased equity. The equity ratio has decreased significantly over the years, indicating higher financial risk. Stockholders' equity has been notably reduced from 2020 to 2024, reflecting financial instability.
Cash Flow
40
Negative
The company's cash flow statements reveal a volatile and declining cash flow position. Negative free cash flow and operating cash flow over the recent years highlight liquidity issues. Although there was a positive operating cash flow in 2021, overall cash flow management remains a concern due to substantial negative free cash flow.
Breakdown
TTMMar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Income StatementTotal Revenue
23.27M38.96M55.35M54.24M53.89M144.59M
Gross Profit
7.46M18.67M27.01M26.66M26.45M61.00M
EBIT
597.50K-16.04M-5.24M-5.89M-37.05M-48.58M
EBITDA
-4.41M-10.12M1.83M4.38M-23.55M-22.43M
Net Income Common Stockholders
-2.35M-17.11M-5.88M-12.69M-30.18M-49.50M
Balance SheetCash, Cash Equivalents and Short-Term Investments
91.04M3.88M18.36M25.15M44.89M56.16M
Total Assets
1.37B29.15M41.70M60.45M191.38M183.17M
Total Debt
247.35M12.23M4.49M7.36M29.73M21.19M
Net Debt
170.12M8.59M-13.19M-9.43M-8.34M-34.25M
Total Liabilities
498.02M27.74M22.32M34.08M158.48M111.40M
Stockholders Equity
836.99M4.36M22.19M29.59M40.23M77.42M
Cash FlowFree Cash Flow
-15.78M-15.35M-3.84M-24.51M-21.21M-52.13M
Operating Cash Flow
-1.29M-854.00K-1.32M-22.93M1.25M35.36M
Investing Cash Flow
-1.68M-14.46M5.74M2.19M-24.28M-82.79M
Financing Cash Flow
2.39M4.36M-2.75M-5.61M4.83M-23.33M

Good Fellow Healthcare Holdings Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.13
Price Trends
50DMA
0.08
Positive
100DMA
0.07
Positive
200DMA
0.07
Positive
Market Momentum
MACD
0.01
Negative
RSI
55.28
Neutral
STOCH
21.20
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:8143, the sentiment is Positive. The current price of 0.13 is above the 20-day moving average (MA) of 0.10, above the 50-day MA of 0.08, and above the 200-day MA of 0.07, indicating a bullish trend. The MACD of 0.01 indicates Negative momentum. The RSI at 55.28 is Neutral, neither overbought nor oversold. The STOCH value of 21.20 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:8143.

Good Fellow Healthcare Holdings Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (54)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
54
Neutral
$5.37B3.35-45.10%2.79%16.77%-0.01%
51
Neutral
HK$127.38M-18.22%-56.16%62.50%
$124.52B6.11
5.94%
$5.45B24.761.57%4.80%
$1.88B87.770.96%
68
Neutral
HK$750.40M12.737.83%1.96%-32.15%
48
Neutral
HK$594.23M-10.78%-0.95%-128.35%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:8143
Good Fellow Healthcare Holdings Limited
0.11
-0.04
-26.67%
PIAIF
Ping An Insurance Company of China
6.08
1.59
35.41%
CCGDF
China Cinda Asset Management Co
0.13
0.04
44.44%
PANHF
Ping An Healthcare and Technology Company
0.92
0.76
475.00%
HK:3869
Hospital Corporation of China Ltd
4.30
-2.10
-32.81%
HK:6093
Hevol Services Group Co. Limited
1.34
-0.18
-11.84%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.